Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trial.

Williams SC, Marshall NS, Kennerson M, Rogers NL, Liu PY, Grunstein RR.

Am J Respir Crit Care Med. 2010 Apr 15;181(8):825-31. doi: 10.1164/rccm.200908-1307OC. Epub 2010 Jan 7.

PMID:
20056901
2.

The effect of modafinil following acute CPAP withdrawal: a preliminary study.

Williams SC, Rogers NL, Marshall NS, Leung S, Starmer GA, Grunstein RR.

Sleep Breath. 2008 Nov;12(4):359-64. doi: 10.1007/s11325-008-0175-9. Epub 2008 Mar 1.

PMID:
18311493
3.

Modafinil Increases Awake EEG Activation and Improves Performance in Obstructive Sleep Apnea during Continuous Positive Airway Pressure Withdrawal.

Wang D, Bai XX, Williams SC, Hua SC, Kim JW, Marshall NS, D'Rozario A, Grunstein RR.

Sleep. 2015 Aug 1;38(8):1297-303. doi: 10.5665/sleep.4912.

4.

Placebo and modafinil effect on sleepiness in obstructive sleep apnea.

Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, Tufik S.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):552-9. Epub 2007 Oct 30.

PMID:
18053628
5.

Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.

Chapman JL, Kempler L, Chang CL, Williams SC, Sivam S, Wong KK, Yee BJ, Grunstein RR, Marshall NS.

Thorax. 2014 Mar;69(3):274-9. doi: 10.1136/thoraxjnl-2013-203796. Epub 2013 Nov 28.

PMID:
24287166
8.
10.

Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.

Herring WJ, Liu K, Hutzelmann J, Snavely D, Snyder E, Ceesay P, Lines C, Michelson D, Roth T.

Sleep Med. 2013 Oct;14(10):955-63. doi: 10.1016/j.sleep.2013.04.010. Epub 2013 Aug 3.

PMID:
23920422
11.

Driving simulator performance remains impaired in patients with severe OSA after CPAP treatment.

Vakulin A, Baulk SD, Catcheside PG, Antic NA, van den Heuvel CJ, Dorrian J, McEvoy RD.

J Clin Sleep Med. 2011 Jun 15;7(3):246-53. doi: 10.5664/JCSM.1062.

12.

Modafinil improves alertness, vigilance, and executive function during simulated night shifts.

Walsh JK, Randazzo AC, Stone KL, Schweitzer PK.

Sleep. 2004 May 1;27(3):434-9.

PMID:
15164895
13.

Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.

Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W.

Sleep. 2002 Dec;25(8):905-9.

PMID:
12489899
14.

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome.

Kingshott RN, Vennelle M, Coleman EL, Engleman HM, Mackay TW, Douglas NJ.

Am J Respir Crit Care Med. 2001 Mar;163(4):918-23.

PMID:
11282766
15.

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy.

Broughton RJ, Fleming JA, George CF, Hill JD, Kryger MH, Moldofsky H, Montplaisir JY, Morehouse RL, Moscovitch A, Murphy WF.

Neurology. 1997 Aug;49(2):444-51.

PMID:
9270575
16.

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.

Schwartz JR, Hirshkowitz M, Erman MK, Schmidt-Nowara W.

Chest. 2003 Dec;124(6):2192-9.

PMID:
14665500
17.

Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.

Hirshkowitz M, Black JE, Wesnes K, Niebler G, Arora S, Roth T.

Respir Med. 2007 Mar;101(3):616-27. Epub 2006 Aug 14.

Items per page

Supplemental Content

Write to the Help Desk